Patient-reported voice and speech outcomes after whole-neck intensity modulated radiation therapy and chemotherapy for oropharyngeal cancer: Prospective longitudinal study

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 5, 2014, Pages 973-980

  Vainshtein, Jeffrey M ^a   Griffith, Kent A ^c   Feng, Felix Y ^a   Vineberg, Karen A ^a   Chepeha, Douglas B ^b   Eisbruch, Avraham ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DISEASES; PHYSICAL THERAPY; RADIOTHERAPY; SPEECH;

AS LOW AS REASONABLY ACHIEVABLE; COMMUNICATION DOMAIN; INTENSITY MODULATED RADIATION THERAPY; LONGITUDINAL STUDY; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; OROPHARYNGEAL CANCER; UNIVERSITY OF WASHINGTON;

SPEECH COMMUNICATION;

CARBOPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT; FEMALE; GLOTTIS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION DOSE; SPEECH; SPEECH DISORDER; VOICE;

ADULT; AGED; CHEMORADIOTHERAPY; FEMALE; GLOTTIS; HUMANS; LARYNX; MALE; MIDDLE AGED; NECK DISSECTION; OBSERVER VARIATION; ORGAN SPARING TREATMENTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; SPEECH; SPEECH DISORDERS; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS; VOICE DISORDERS; VOICE QUALITY;

EID: 84904207662     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.03.013     Document Type: Article

References (30)

1. K.U. Hunter, M. Schipper, and F.Y. Feng et al. Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: Prospective study of patient-reported, observer-rated, and objective outcomes Int J Radiat Oncol Biol Phys 85 2013 935 940
2. M.L. Stoicheff Voice following radiotherapy Laryngoscope 85 1975 608 618
3. K. Fung, J. Yoo, and H.A. Leeper et al. Vocal function following radiation for non-laryngeal versus laryngeal tumors of the head and neck Laryngoscope 111 2001 1920 1924
4. G. Sanguineti, F. Ricchetti, and T. McNutt et al. Dosimetric predictors of dysphonia after intensity-modulated radiotherapy for oropharyngeal carcinoma Clin Oncol (R Coll Radiol) 26 2014 32 38
5. K. Dornfeld, J.R. Simmons, and L. Karnell et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life Int J Radiat Oncol Biol Phys 68 2007 750 757
6. I. Jacobi, L. van der Molen, and H. Huiskens et al. Voice and speech outcomes of chemoradiation for advanced head and neck cancer: A systematic review Eur Arch Otorhinolaryngol 267 2010 1495 1505
7. L. van der Molen, M.A. van Rossum, and I. Jacobi et al. Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: Expert listeners' and patient's perception J Voice 26 2012 664.e25 664.e633
8. A. Eisbruch, H.M. Kim, and F.Y. Feng et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: Swallowing organs late complication probabilities and dosimetric correlates Int J Radiat Oncol Biol Phys 81 2011 e93 e99
9. F.Y. Feng, H.M. Kim, and T.H. Lyden et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: Clinical and functional results J Clin Oncol 28 2010 2732 2738
10. K.U. Hunter, L.L. Fernandes, and K.A. Vineberg et al. Parotid glands dose-effect relationships based on their actually delivered doses: Implications for adaptive replanning in radiation therapy of head-and-neck cancer Int J Radiat Oncol Biol Phys 87 2013 676 682
11. M. Little, M. Schipper, and F.Y. Feng et al. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: Beyond sparing the parotid glands Int J Radiat Oncol Biol Phys 83 2012 1007 1014
12. J.E. Terrell, K.A. Nanavati, and R.M. Esclamado et al. Head and neck cancer-specific quality of life: Instrument validation Arch Otolaryngol Head Neck Surg 123 1997 1125 1132
13. S.J. Hassan, and E.A. Weymuller Jr. Assessment of quality of life in head and neck cancer patients Head Neck 15 1993 485 496
14. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
15. B. Kumar, K.G. Cordell, and J.S. Lee et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26 2008 3128 3137
16. A.L. Tang, S.J. Hauff, and J.H. Owen et al. UM-SCC-104: A new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line Head Neck 34 2012 1480 1491
17. C. Myers, P. Kerr, and A. Cooke et al. Functional outcomes after treatment of advanced oropharyngeal carcinoma with radiation or chemoradiation J Otolaryngol Head Neck Surg 41 2012 108 118
18. K. Fung, J. Yoo, and H.A. Leeper et al. Effects of head and neck radiation therapy on vocal function J Otolaryngol 30 2001 133 139
19. S. Narayan, J. Lehmann, and M.A. Coleman et al. Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy Int J Radiat Oncol Biol Phys 72 2008 756 762
20. T. Dijkema, C.P. Raaijmakers, and R.K. Ten Haken et al. Parotid gland function after radiotherapy: The combined Michigan and Utrecht experience Int J Radiat Oncol Biol Phys 78 2010 449 453
21. G. Sanguineti, P. Adapala, and E.J. Endres et al. Dosimetric predictors of laryngeal edema Int J Radiat Oncol Biol Phys 68 2007 741 749
22. R.J. Amdur, J.G. Li, and C. Liu et al. Unnecessary laryngeal irradiation in the IMRT era Head Neck 26 2004 257 263 discussion 263-254
23. B. Dabaja, M.R. Salehpour, and I. Rosen et al. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: Comparison of split-field and whole-field techniques Int J Radiat Oncol Biol Phys 63 2005 1000 1005
24. J.B. Chung, J.W. Lee, and J.S. Kim et al. Comparison of target coverage and dose to organs at risk between simultaneous integrated-boost whole-field intensity-modulated radiation therapy and junctioned intensity-modulated radiation therapy with a conventional radiotherapy field in treatment of nasopharyngeal carcinoma Radiol Phys Technol 4 2011 180 184
25. G.J. Webster, C.G. Rowbottom, and K.F. Ho et al. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck Int J Radiat Oncol Biol Phys 72 2008 617 622
26. V. Bar Ad, H. Lin, and W.T. Hwang et al. Larynx-sparing techniques using intensity-modulated radiation therapy for oropharyngeal cancer Med Dosim 37 2012 383 386
27. K.S. Chao, G. Ozyigit, and B.N. Tran et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer Int J Radiat Oncol Biol Phys 55 2003 312 321
28. I. Gluck, F.Y. Feng, and T. Lyden et al. Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer Int J Radiat Oncol Biol Phys 77 2010 727 733
29. A. Meirovitz, C.A. Murdoch-Kinch, and M. Schipper et al. Grading xerostomia by physicians or by patients after IMRT of head and neck cancer Int J Radiat Onc Biol Phys 66 2006 445 453
30. E. Basch Toward patient-centered drug development in oncology N Engl J Med 369 2013 397 400